Hancock Whitney Corp Sells 70,371 Shares of Medical Properties Trust, Inc. (NYSE:MPW)

Hancock Whitney Corp decreased its holdings in shares of Medical Properties Trust, Inc. (NYSE:MPW) by 26.2% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 198,429 shares of the real estate investment trust’s stock after selling 70,371 shares during the period. Hancock Whitney Corp’s holdings in Medical Properties Trust were worth $4,189,000 as of its most recent SEC filing.

A number of other large investors have also bought and sold shares of MPW. Van Hulzen Asset Management LLC raised its position in Medical Properties Trust by 1.1% during the third quarter. Van Hulzen Asset Management LLC now owns 45,800 shares of the real estate investment trust’s stock valued at $896,000 after purchasing an additional 500 shares in the last quarter. Private Ocean LLC purchased a new stake in Medical Properties Trust during the third quarter valued at about $50,000. IFP Advisors Inc raised its position in Medical Properties Trust by 5.1% during the fourth quarter. IFP Advisors Inc now owns 10,350 shares of the real estate investment trust’s stock valued at $213,000 after purchasing an additional 503 shares in the last quarter. Ellis Investment Partners LLC raised its position in Medical Properties Trust by 1.3% during the fourth quarter. Ellis Investment Partners LLC now owns 41,805 shares of the real estate investment trust’s stock valued at $869,000 after purchasing an additional 541 shares in the last quarter. Finally, Renaissance Group LLC raised its position in Medical Properties Trust by 6.2% during the third quarter. Renaissance Group LLC now owns 11,561 shares of the real estate investment trust’s stock valued at $226,000 after purchasing an additional 671 shares in the last quarter. 72.14% of the stock is owned by institutional investors.

In other news, COO Emmett E. Mclean sold 100,000 shares of Medical Properties Trust stock in a transaction dated Wednesday, January 8th. The stock was sold at an average price of $20.84, for a total value of $2,084,000.00. Following the transaction, the chief operating officer now owns 1,003,415 shares in the company, valued at $20,911,168.60. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, Director Michael G. Stewart sold 4,800 shares of Medical Properties Trust stock in a transaction dated Wednesday, December 4th. The stock was sold at an average price of $21.27, for a total value of $102,096.00. 1.18% of the stock is currently owned by insiders.

A number of research firms have weighed in on MPW. ValuEngine upgraded Medical Properties Trust from a “sell” rating to a “hold” rating in a research report on Tuesday, December 3rd. TheStreet upgraded Medical Properties Trust from a “c+” rating to a “b” rating in a research report on Thursday, February 6th. Zacks Investment Research upgraded Medical Properties Trust from a “hold” rating to a “buy” rating and set a $24.00 price target on the stock in a research report on Wednesday, January 8th. Mizuho raised their price target on Medical Properties Trust from $25.00 to $26.00 and gave the company a “buy” rating in a research report on Thursday, December 26th. Finally, Barclays set a $22.00 price target on Medical Properties Trust and gave the company a “buy” rating in a research report on Monday, October 21st. Three equities research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. The company presently has an average rating of “Buy” and an average price target of $21.59.

MPW opened at $23.61 on Friday. The company has a market cap of $12.19 billion, a P/E ratio of 27.45, a P/E/G ratio of 3.20 and a beta of 0.58. The business’s 50-day moving average price is $21.98 and its 200-day moving average price is $20.11. The company has a current ratio of 9.45, a quick ratio of 6.27 and a debt-to-equity ratio of 1.00. Medical Properties Trust, Inc. has a 12 month low of $16.83 and a 12 month high of $23.76.

Medical Properties Trust (NYSE:MPW) last released its quarterly earnings data on Thursday, February 6th. The real estate investment trust reported $0.26 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.35 by ($0.09). The company had revenue of $256.44 million during the quarter, compared to analysts’ expectations of $263.35 million. Medical Properties Trust had a return on equity of 6.57% and a net margin of 43.86%. The firm’s quarterly revenue was up 42.0% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.31 EPS. Equities research analysts forecast that Medical Properties Trust, Inc. will post 1.68 earnings per share for the current fiscal year.

Medical Properties Trust Profile

Medical Properties Trust, Inc is a self-advised real estate investment trust formed to capitalize on the changing trends in healthcare delivery by acquiring and developing net-leased healthcare facilities. MPT's financing model helps facilitate acquisitions and recapitalizations and allows operators of hospitals and other healthcare facilities to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations.

Read More: How does a dividend reinvestment plan work?

Want to see what other hedge funds are holding MPW? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Medical Properties Trust, Inc. (NYSE:MPW).

Institutional Ownership by Quarter for Medical Properties Trust (NYSE:MPW)

Receive News & Ratings for Medical Properties Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply